Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.John Newman is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
Buy Now | Get Alert | ||||||||
---|---|---|---|---|---|---|---|---|---|
06/27/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | 9.61% | $1152 → $1152 | Maintains | Buy | Get Alert |
06/07/2024 | MCRB | Buy Now | Seres Therapeutics | $0.78 | 1182.05% | $15 → $10 | Maintains | Buy | Get Alert |
06/04/2024 | MRUS | Buy Now | Merus | $59.17 | 13.23% | $54 → $67 | Maintains | Buy | Get Alert |
05/16/2024 | APTO | Buy Now | Aptose Biosciences | $0.76 | 689.58% | $15 → $6 | Maintains | Buy | Get Alert |
05/13/2024 | OCUP | Buy Now | Ocuphire Pharma | $1.57 | 1046.5% | $22 → $18 | Maintains | Buy | Get Alert |
05/09/2024 | TSVT | Buy Now | 2seventy bio | $3.85 | 185.71% | $12 → $11 | Maintains | Buy | Get Alert |
03/20/2024 | ACET | Buy Now | Adicet Bio | $1.25 | 1420% | → $19 | Reiterates | Buy → Buy | Get Alert |
02/29/2024 | ACLX | Buy Now | Arcellx | $55.19 | 54.01% | $66 → $85 | Maintains | Buy | Get Alert |
01/05/2024 | ACET | Buy Now | Adicet Bio | $1.25 | 1420% | $21 → $19 | Maintains | Buy | Get Alert |
11/16/2023 | ACLX | Buy Now | Arcellx | $55.19 | 19.59% | $49 → $66 | Maintains | Buy | Get Alert |
11/09/2023 | ACET | Buy Now | Adicet Bio | $1.25 | 1580% | $28 → $21 | Maintains | Buy | Get Alert |
08/21/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -5.62% | $720 → $992 | Upgrade | Hold → Buy | Get Alert |
08/18/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -31.5% | $720 → $720 | Maintains | Hold | Get Alert |
08/01/2023 | IMGN | Buy Now | Immunogen | — | — | $23 → $25 | Maintains | Buy | Get Alert |
06/28/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -31.5% | $953 → $720 | Downgrade | Buy → Hold | Get Alert |
06/23/2023 | ONCY | Buy Now | Oncolytics Biotech | $1.00 | 400% | → $5 | Reiterates | Buy → Buy | Get Alert |
06/21/2023 | ACLX | Buy Now | Arcellx | $55.19 | -11.22% | → $49 | Reiterates | Buy → Buy | Get Alert |
06/16/2023 | ALLO | Buy Now | Allogene Therapeutics | $2.33 | 1402.15% | → $35 | Reiterates | Buy → Buy | Get Alert |
06/12/2023 | IMGN | Buy Now | Immunogen | — | — | → $19 | Reiterates | Buy → Buy | Get Alert |
06/05/2023 | IMGN | Buy Now | Immunogen | — | — | $15 → $19 | Maintains | Buy | Get Alert |
05/09/2023 | ATRA | Buy Now | Atara Biotherapeutics | $8.50 | 135.29% | $1250 → $500 | Maintains | Buy | Get Alert |
04/26/2023 | ACLX | Buy Now | Arcellx | $55.19 | -11.22% | $40 → $49 | Maintains | Buy | Get Alert |
04/19/2023 | ACLX | Buy Now | Arcellx | $55.19 | -27.52% | $34 → $40 | Maintains | Buy | Get Alert |
03/21/2023 | MCRB | Buy Now | Seres Therapeutics | $0.78 | 1823.08% | $11 → $15 | Maintains | Buy | Get Alert |
03/08/2023 | MCRB | Buy Now | Seres Therapeutics | $0.78 | 1310.26% | $17 → $11 | Maintains | Buy | Get Alert |
03/06/2023 | ONCY | Buy Now | Oncolytics Biotech | $1.00 | 400% | $6 → $5 | Maintains | Buy | Get Alert |
01/31/2023 | SELB | Buy Now | Selecta Biosciences | — | — | $10 → $9 | Maintains | Buy | Get Alert |
11/16/2022 | IMGN | Buy Now | Immunogen | — | — | $12 → $15 | Maintains | Buy | Get Alert |
09/16/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -28.64% | $700 → $750 | Maintains | Buy | Get Alert |
08/08/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | $40 → $72 | Upgrade | Hold → Buy | Get Alert |
07/20/2022 | ACLX | Buy Now | Arcellx | $55.19 | -42.02% | → $32 | Initiates | → Buy | Get Alert |
02/16/2022 | AGIO | Buy Now | Agios Pharmaceuticals | $43.12 | 2.04% | $52 → $44 | Maintains | Buy | Get Alert |